Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Liver cirrhosis

UCL study reveals carbon beads could help reduce progression of liver disease

Liver cirrhosis, caused by long-term liver damage, is estimated to affect around 100 million people worldwide

April 16, 2024 CARBALIVE, gut health, Liver cirrhosis, liver disease, microbiome health, News, University College London, Yaqrit

New clinical study to advance development of treatments for liver cirrhosis

The £30m ADVANCE study is the most extensive study into liver disease worldwide

January 10, 2024 Accelerating Discovery: Actionable NASH Cirrhosis Endpoints, Boehringer Ingelheim, Liver cirrhosis, Newcastle University, News, University of Edinburgh
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy